Home > Library > AYA fintech network platform: major milestones, key product features, and online social network services
Author Chanel Holden
Our fintech finbuzz analytic report shines light on the current global macro-financial outlook. As of Summer-Fall 2023, this report focuses on the major milestones, key product features, and online social media services across our AYA fintech network platform. The AYA major milestones include our proprietary alpha stock investment model configuration, U.S. fintech patent protection and accreditation for 20 years, landmark ebook publications on the Trump to Biden economic policy reforms, and new empirical research articles on macrofinance, asset return prediction, financial intermediary capital structure, and corporate ownership governance. We include a complete fintech founder profile toward the end of this report.
Description:
Our fintech finbuzz analytic report shines light on the current global macro-financial outlook. As of Summer-Fall 2023, this report focuses on the major milestones, key product features, and online social media services across our AYA fintech network platform. The AYA major milestones include our proprietary alpha stock investment model configuration, U.S. fintech patent protection and accreditation for 20 years, landmark ebook publications on the Trump to Biden economic policy reforms, and new empirical research articles on macrofinance, asset return prediction, financial intermediary capital structure, and corporate ownership governance. We include a complete fintech founder profile toward the end of this report.
This analytic report cannot constitute any form of financial advice, analyst opinion, recommendation, or endorsement. We refrain from engaging in financial advisory services, and we seek to offer our analytic insights into the latest economic trends, stock market topics, investment memes, and other financial issues. Our proprietary alpha investment algorithmic system helps enrich our AYA fintech network platform as a new social community for stock market investors: https://ayafintech.network.
We share and circulate these informative posts and essays with hyperlinks through our blogs, podcasts, emails, social media channels, and patent specifications. Our goal is to help promote better financial literacy, inclusion, and freedom of the global general public. While we make a conscious effort to optimize our global reach, this optimization retains our current focus on the American stock market.
This free ebook, AYA Analytica, shares new economic insights, investment memes, and stock portfolio strategies through both blog posts and patent specifications on our AYA fintech network platform. AYA fintech network platform is every investor’s social toolkit for profitable investment management. We can help empower stock market investors through technology, education, and social integration.
We hope you enjoy the substantive content of this ebook! AYA!
Andy Yeh
Chief Financial Architect (CFA) and Financial Risk Manager (FRM)
Brass Ring International Density Enterprise (BRIDE) ©
2025-10-10 12:31:00 Friday ET
Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund
2017-08-19 14:43:00 Saturday ET
In a recent tweet, President Donald Trump criticizes Amazon over taxes and jobs. Without providing specific evidence, Trump accuses of the e-commerce retail
2018-06-17 10:35:00 Sunday ET
In the past decades, capital market liberalization and globalization have combined to connect global financial markets to allow an ocean of money to flow th
2019-06-27 10:39:00 Thursday ET
Berkeley tax economists Gabriel Zucman and Emmanuel Saez find fresh insights into wealth inequality in America. Their latest estimates show that the top 0.1
2017-08-31 09:36:00 Thursday ET
The Trump administration has initiated a new investigation into China's abuse of American intellectual property under Section 301 of the Trade Act of 19
2018-10-15 09:33:00 Monday ET
Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an
